Literature DB >> 29242570

Monitoring cerebral oxygenation of preterm infants using a neonatal specific sensor.

M Kenosi1,2, J M O'Toole1,2, G A Hawkes1,2, W Hutch1,2, E Low1,2, M Wall1, G B Boylan1,2, C A Ryan1,2, E M Dempsey3,4.   

Abstract

INTRODUCTION: Cerebral oxygenation (rcSO2) monitoring in preterm infants may identify periods of cerebral hypoxia or hyperoxia. We hypothesised that there was a relationship between rcSO2 values and short term outcome in infants of GA < 32weeks.
METHODS: RcSO2 values were recorded for the first 48 h of life using an INVOS monitor with a neonatal sensor. The association between cranial ultrasound scan measured brain injury and rcSO2 was assessed.
RESULTS: 120 infants were included. Sixty-nine percent (83) of infants had a normal outcome (no IVH, no PVL, and survival at 1 month); less than one-quarter, 22% (26), had low grade IVH 1 or 2 (moderate outcome); and 9% (11) of infants had a severe outcome (IVH ≥ 3, PVL or died before 1 month age). rcSO2 values were lower for infants GA < 28weeks when compared with those GA 28-32, p < 0.001. There was no difference in absolute rcSO2 values between the three outcome groups but a greater degree of cerebral hypoxia was associated with preterm infants who had low grade 1 or 2 IVH.
CONCLUSION: Infants of GA < 28 weeks have lower cerebral oxygenation in the first 2 days of life. A greater degree of hypoxia was seen in infants with grade 1 or 2 haemorrhage. Normative ranges need to be gestation specific.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29242570     DOI: 10.1038/s41372-017-0007-5

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  3 in total

1.  Temporal evolution of quantitative EEG within 3 days of birth in early preterm infants.

Authors:  John M O'Toole; Elena Pavlidis; Irina Korotchikova; Geraldine B Boylan; Nathan J Stevenson
Journal:  Sci Rep       Date:  2019-03-19       Impact factor: 4.379

2.  Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial.

Authors:  Anne Mette Plomgaard; Christoph E Schwarz; Olivier Claris; Eugene M Dempsey; Monica Fumagalli; Simon Hyttel-Sorensen; Petra Lemmers; Adelina Pellicer; Gerhard Pichler; Gorm Greisen
Journal:  PLoS One       Date:  2022-01-24       Impact factor: 3.240

Review 3.  Monitoring Circulation During Transition in Extreme Low Gestational Age Newborns: What's on the Horizon?

Authors:  David Van Laere; Michiel Voeten; John M O' Toole; Eugene Dempsey
Journal:  Front Pediatr       Date:  2018-03-26       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.